- Home
- RYTM vs PRGS Comparison
RYTM vs PRGS Comparison
Compare RYTM & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- PRGS
- Stock Information
- Founded
- RYTM 2008
- PRGS 1981
- Country
- RYTM United States
- PRGS United States
- Employees
- RYTM N/A
- PRGS N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- PRGS Computer Software: Prepackaged Software
- Sector
- RYTM Health Care
- PRGS Technology
- Exchange
- RYTM Nasdaq
- PRGS Nasdaq
- Market Cap
- RYTM 3.1B
- PRGS 2.9B
- IPO Year
- RYTM 2017
- PRGS 1991
- Fundamental
- Price
- RYTM $56.12
- PRGS $66.38
- Analyst Decision
- RYTM Strong Buy
- PRGS Buy
- Analyst Count
- RYTM 10
- PRGS 6
- Target Price
- RYTM $65.80
- PRGS $67.67
- AVG Volume (30 Days)
- RYTM 552.7K
- PRGS 537.8K
- Earning Date
- RYTM 11-05-2024
- PRGS 01-14-2025
- Dividend Yield
- RYTM N/A
- PRGS 1.05%
- EPS Growth
- RYTM N/A
- PRGS 5.04
- EPS
- RYTM N/A
- PRGS 1.86
- Revenue
- RYTM $112,530,000.00
- PRGS $715,418,000.00
- Revenue This Year
- RYTM $63.64
- PRGS $10.13
- Revenue Next Year
- RYTM $42.98
- PRGS $22.59
- P/E Ratio
- RYTM N/A
- PRGS $35.72
- Revenue Growth
- RYTM 81.55
- PRGS 6.05
- 52 Week Low
- RYTM $35.17
- PRGS $48.00
- 52 Week High
- RYTM $68.58
- PRGS $70.56
- Technical
- Relative Strength Index (RSI)
- RYTM 46.95
- PRGS 42.26
- Support Level
- RYTM $53.39
- PRGS $68.35
- Resistance Level
- RYTM $57.27
- PRGS $69.79
- Average True Range (ATR)
- RYTM 2.32
- PRGS 1.41
- MACD
- RYTM -0.55
- PRGS -0.46
- Stochastic Oscillator
- RYTM 33.21
- PRGS 15.77
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.
About PRGS Progress Software Corporation (DE)
Progress Software Corporation is a provider of cloud-based security solutions to large-and mid-sized organizations in a wide range of industries. Its product includes OpenEdge; Chef; Developer Tools; Kemp LoadMaster; MOVEit; DataDirect; WhatsUp Gold; Sitefinity; Flowmon and Corticon. The company derives revenue from perpetual licenses to its products, but some products also use term licensing models. Its cloud-based offerings use a subscription-based model. A majority of the firm's revenue is generated in the United States and it also has presence in Canada, the Middle East, and Africa (EMEA), Latin America, and Asia Pacific.